Office-Based Treatment of Opioid-Dependent Patients
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
A 30-year-old man reports a two-year history of heroin use. For the past year, he has been using intranasal heroin every day. He has undergone detoxification twice at a local opioid-abuse treatment program but began using heroin within two days after discharge each time. He has heard of methadone but fears that he will lose his business if he is recognized attending the local program. How should this patient be treated?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatment of OUD with B/N has been shown to be medically effective (increasing retention in treatment and decreasing use of illicit opioids) and cost-effective.3–8”
From Implementing Group Visits for Opioid Use Disorder: A Case Series (2020) · cites this paper as [6]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcome
Ball, J. C., & Ross, A. O. (1991) · Cited by 903
The Effects of Psychosocial Services in Substance Abuse Treatment
McLellan, A. T. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500150065028 · Cited by 869
Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid Abusers
Brooner, R. K. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130077015 · Cited by 746
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS).
Hubbard, R. L., Craddock, S. G., Flynn, P. M., Anderson, J., & Etheridge, R. M. (1997) · Psychology of Addictive Behaviors · doi:10.1037//0893-164x.11.4.261 · Cited by 602
The Effectiveness of Methadone Maintenance Treatment
Ball, J. C., & Ross, A. (1991) · Springer eBooks · doi:10.1007/978-1-4613-9089-3 · Cited by 590
Effective Medical Treatment of Opiate Addiction
Addiction, N. C. D. P. O. E. M. T. O. O. (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.280.22.1936 · Cited by 577
Metzger, D. S., WOODY, G. E., McLellan, A. T., O’Brien, C. P., Druley, P., Navaline, H. A., DePhilippis, D., Stolley, P. D., & Abrutyn, E. (1993) · PubMed · Cited by 530
Sees, K. L., Delucchi, K. L., Masson, C., Rosen, A., Clark, H. W., Robillard, H., Banys, P., & Hall, S. M. (2000) · JAMA · doi:10.1001/jama.283.10.1303 · Cited by 415
Research works printed but not linked: 8
- 2001, Fed Regist, 66, 4076
- 2002, Fed Regist, 67, 13114
- AMA home page. Chicago: American Medical Association, 2002. (Accessed August 19, 2002, at http://www.ama-assn.org/.)
- Gowing L, 2000, Cochrane Database Syst Rev, 2, CD002021
- 10.1037/0893-164X.11.4.261 · DOI · Paper page
- Metzger DS, 1993, J Acquir Immune Defic Syndr, 6, 1049
- Salsitz EA, 2000, Mt Sinai J Med, 67, 388
- National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. Bethesda, Md.: National Institutes of Health, 1998. (Accessed August 19, 2002, at http://odp.od.nih.gov/consensus/cons/108/108_intro.htm.) · DOI · Paper page
Cited by
Items 101–148 of 148
Treatment of alcohol and other drug dependence
Saitz, R. (2007) · Liver Transplantation · doi:10.1002/lt.21339 · Cited by 13
Physician Training is Never a Failure
Gordon, A. J., Liberto, J. C., Granda, S. E., Salmon‐Cox, S., Andrée, T., & McNicholas, L. F. (2009) · American Journal on Addictions · doi:10.1080/10550490902931373 · Cited by 11
Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services
Whitley, S. D., Kunins, H. V., Arnsten, J. H., & Gourevitch, M. N. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.11.003 · Cited by 11
Buprenorphine Maintenance: Office-Based Treatment with Addiction Clinic Support
Ortner, R., Jagsch, R., Schindler, S. D., Primorac, A., Fischer, G., & A Team (2004) · European Addiction Research · doi:10.1159/000077698 · Cited by 12
Addictions à l'héroïne et à la cocaïne
Dervaux, A., & Laqueille, X. (2009) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(09)48129-x · Cited by 15
Wong, J. G., Holmboe, E. S., Becker, W. C., Fiellin, D. A., Jara, G. B., & Martin, J. (2005) · Substance Abuse · doi:10.1300/j465v25n04_05 · Cited by 10
Self-citationMack, A. H., & FRANCES, R. J. (2003) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.1.2.125 · Cited by 12
Bruce, R. D., Smith-Rohrberg, D., & Altice, F. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-71695-4_23 · Cited by 9
Trends in the use of buprenorphine by office-based physicians in the United States, 2003-2013
Turner, L. W., Kruszewski, S. P., & Alexander, G. C. (2014) · American Journal on Addictions · doi:10.1111/j.1521-0391.2014.12174.x · Cited by 7
Low-dose naloxone provides an abuse-deterrent effect to buprenorphine
Webster, L. R., Smith, M. J., Unal, C., & Finn, A. L. (2015) · Journal of Pain Research · doi:10.2147/jpr.s90780 · Cited by 7
Anticipating and treating opioid-associated adverse effects
Herndon, C. M., Kalauokalani, D. A., Cunningham, A. J., Jackson, K. C., & Dunteman, E. D. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.3.305 · Cited by 7
Methadone syrup injection in Australia: a sentinel finding?
Fiellin, D. A., & Lintzeris, N. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00340.x · Cited by 7
Self-citationBuprenorphine for Opioid Dependence
Gordon, A. J., & Krumm, M. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398338-1.00044-0 · Cited by 7
Using buprenorphine for outpatient opioid detoxification.
Manlandro, J. J. (2007) · PubMed · Cited by 6
International Expansion of the Use of Pharmacotherapies for the Treatment of Opioid Dependence
Kresina, T. F. (2012) · Clinical and Experimental Pharmacology · doi:10.4172/2161-1459.s5-001 · Cited by 5
Buprenorphine: A New Alternative in the Treatment of Opioid Addiction
Tellioğlu, T. (2010) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.1080/10177833.2010.11790670 · Cited by 9
“In October 2002, the American Food and Drug Administration (FDA) agency approved buprenorphine monotherapy product, Subutex®, and a buprenorphine/ naloxone combination product, Suboxone®, for use in opioid addiction treatment in office-based settings (13,14).”
BackgroundAssessing and Comparing Attitudes Toward Addiction and Methadone Treatment
Evans, J. S. (2006) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 5
HIV Disease Among Substance Users: Treatment Issues
Bruce, R. D., Altice, F. L., & Friedland, G. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-2882-6.50048-4 · Cited by 4
Trust Violated: Analgesics for Addicts
Penson, R. T., Nunn, C., Younger, J., Schaeffer, N. J., Chabner, B. A., Fricchione, G. L., Quinn, T. E., & Lynch, T. J. (2003) · The Oncologist · doi:10.1634/theoncologist.8-2-199 · Cited by 4
Buprenorphine for pain management physicians: A dilemma or a therapeutic alternative?
Myers, D. P., Augustyniak, M., & Molea, J. (2005) · Techniques in Regional Anesthesia and Pain Management · doi:10.1053/j.trap.2005.10.007 · Cited by 4
Nurse-Sensitive Indicators in the Care of Individuals With Opioid Use Disorder
Bernhardt, J. M. (2021) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000431 · Cited by 3
“In 2002, amid the ongoing opioid crisis, primary care settings began offering medication-assisted treatment for OUD with buprenorphine hydrochloride (Fiellin & O'Connor, 2002) as an alternative to treatment with methadone.”
BackgroundExploration of drug addiction prevalence among young generation of Pabna district, Bangladesh
Sarker, A. K., Raju, F. R., Sultana, M. P., Milon, M. M. M., & Akter, S. (2023) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v13i3.5764 · Cited by 3
Buprenorphine: A Guide for Nurses (Technical Assistance Publication)
Azimi-Bolourian, S., & Fornili, K. S. (2010) · Journal of Addictions Nursing · doi:10.3109/10884601003628146 · Cited by 3
Pharmacotherapies for treating opioid use disorder
Nguyen, T. A., Hahn, J. H., & Strakowski, S. M. (2013) · CNS Spectrums · doi:10.1017/s1092852913000229 · Cited by 3
An evaluation of a harm reduction Summer School for undergraduate health professional students
Sheridan, J. L., Adams, P. J., Bullen, C., & Newcombe, D. A. L. (2017) · Drugs Education Prevention and Policy · doi:10.1080/09687637.2016.1262824 · Cited by 5
Interruption of medication-assisted treatment for opioid dependence: insights from the UK
Alam, F., & Barker, P. (2014) · Drugs and Alcohol Today · doi:10.1108/dat-01-2014-0002 · Cited by 2
Management of the Drug Abusing Patient in the ICU
Deshpande, R. P., Gong, J., Chadha, R., & Haddadin, A. S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1951-2_31 · Cited by 2
Office-Based Treatment of Opioid-Dependent Patients
Ferner, R. E., & Daniels, A. M. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301023480118 · Cited by 2
Brust, J. C. M. (2007) · Elsevier eBooks · doi:10.1016/b978-2-84299-712-0.50003-6 · Cited by 1
Ballantyne, J. C. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_18 · Cited by 1
Managing Pain in the Addicted Patient
Dabu-Bondoc, S. M., Zhang, R. S., & Vadivelu, N. (2010) · Springer eBooks · doi:10.1007/978-0-387-87579-8_31 · Cited by 1
Opioid Dependence: Managing the High Cost of Treatment Failure
Jan, S. A. (2010) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2010.16.s1-b.1 · Cited by 1
Evaluation Of Need And Feasibility Of Tuberculosis Screening In Buprenorphine Treatment Programs
Schwarz, R. K. (2011) · Cited by 1
Farzam, H., Farhadi, K., Rezaei, M., & Tolouee, A. (2010) · Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Kirmānshāh · Cited by 1
Parran, T. V., Mace, A. G., Dahan, Y. J., Adelman, C., & Kolganov, M. (2017) · Substance Abuse Research and Treatment · doi:10.1177/1178221817731320 · Cited by 3
Hernandez, E. M. (2017) · RAND Corporation eBooks · doi:10.7249/rgsd404 · Cited by 1
Niebergall, H. (2007) · Springer eBooks · doi:10.1007/978-3-540-33734-8_2 · Cited by 2
Brust, J. C. M. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7506-7313-6.50007-6 · Cited by 1
Pharmacological Therapeutics for Relapse Reduction in Addictive Disorders
Merlo, L. J., Blumenthal, K. G., Campbell, K. M., Omli, M. R., & Gold, M. S. (2010) · Wiley eBooks · doi:10.1002/9780470710449.ch33
Probleme der medikamentösen Therapie
Glier, B., & Lütz, J. (2010) · Springer eBooks · doi:10.1007/978-3-642-12783-0_35
Balter, R. E. (2013) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/3rgv-2444
Understanding the Agent, Part III: Specific Drugs
McAnally, H. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-47497-7_4
Problem e der medikamentösen Therapie
Lütz, J., & Glier, B. (2016) · Springer eBooks · doi:10.1007/978-3-662-50512-0_22
Bibliography for Substance-Related Disorders
(2003) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.1.2.147
Does Morphine Abuse Harm Male Reproductive System?
Görmüş, Z. I. S., & Koca, R. Ö. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1010051
Brincheiro, W., Chiles, N., Jangro, W. C., Haahr, R., & Weinstein, L. C. (2026) · Harm Reduction Journal · doi:10.1186/s12954-025-01366-x
Modeling Opioid Addiction Treatment Policies Using System Dynamics
Wakeland, W. W., & Nielsen, A. E. (2013) · PDXScholar (Portland State University)
Metadata
- Authors
- Fiellin, D. A., & O'Connor, P. G.
- Affiliations
- Yale University (US)
- ORCID
- Fiellin, David A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-09-12
- Volume
- 347
- Issue
- 11
- Pages
- 817-823
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2092853006
- Cited by
- 148
- References
- 36
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 8 · 2016: 4 · 2015: 6 · 2014: 7 · 2013: 5 · 2012: 4
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (K12DA000167)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- opioid use disorder, heroin use, office-based treatment, methadone maintenance treatment, opioid detoxification, opioid use disorder treatment
- MeSH terms
- Adult, Drug and Narcotic Control, Heroin Dependence, Humans, Male, Methadone, Opioid-Related Disorders, Narcotics, Rehabilitation, United States, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.